Introduction to Human Subjects Protection Challenges in Patient- Centered Outcomes Research (PCOR) Toward Establishing a Stakeholder Community and Action.

Slides:



Advertisements
Similar presentations
Migrant Education Comprehensive Needs Assessment
Advertisements

Is it Research?. Is It Research? 2 Elements –The project involves a systematic investigation –The design (meaning goal, purpose, or intent) of the investigation.
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Engaging Patients and Other Stakeholders in Clinical Research
The Community Engagement Studio: Strengthening Research Capacity through Community Engagement Consuelo H. Wilkins, MD, MSCI Executive Director, Meharry.
Sometimes…. What Seems Unfamiliar and Strange Ends Up Almost Being Business as Usual Margaret D. LeCompte, PhD School of Education University of Colorado-Boulder.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Sue Sheridan, Acting Director, Patient.
Facilitators: Janet Lange and Bob Munn
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Second Legislated Review of Community Treatment Orders Ministry of Health and Long-Term Care November 9, 2012.
IRB 101: Introduction to Human Subject Research
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Chapter 3 Preparing and Evaluating a Research Plan Gay and Airasian
Toolkit Series from the Office of Migrant Education Webinar: CNA Toolkit August 21, 2012.
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
Welcome to the Performance Indicator Data Webinar Hosted by: The Family Institute for Education, Practice & Research The webinar will begin shortly. Thank.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
How to Develop the Right Research Questions for Program Evaluation
Connecting Work and Academics: How Students and Employers Benefit.
FORMATIVE EVALUATION Intermediate Injury Prevention Course August 23-26, 2011, Billings, MT.
Results from 2014 NHSRU-KTEP Environmental Scan Prepared for Policy to Practice – Investing in Your Workforce September 15, 2014 Prepared by the Nursing.
Avoiding the Pitfalls of an IRB Submission Chris Ayres Chair, Institutional Review Board Social & Behavioral Science & Chair, Department of Kinesiology,
From Evidence to Action: Addressing Challenges to Knowledge Translation in RHAs The Need to Know Team Meeting May 30, 2005.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Assessment Cycle California Lutheran University Deans’ Council February 6, 2006.
Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators.
ASTPHND ASTPHND Innovative Applications and Training Strategies.
Nursing Research Capacity Building. Background CON –opened as 9 th College at SQU in 2008 The CON’s next challenge is promoting nursing care based on.
Tips for Researchers on Completing the Data Analysis Section of the IRB Application Don Allensworth-Davies, MSc Statistical Manager, Data Coordinating.
Overview of Program Evaluation Program Evaluation Basics Webinar Series Mary E. Arnold, Ph.D. Associate Professor and Youth Development Specialist Oregon.
Group Technical Assistance Webinar August 5, CFPHE RESEARCH METHODS FOR COMPARATIVE EFFECTIVENESS RESEARCH.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
RESPONSIBLE CONDUCT IN HUMAN SUBJECTS RESEARCH MARGARITA M. CARDONA DIRECTOR OF SPONSORED RESEARCH Institutional Review Board.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Office of Research Integrity and Compliance March 2011.
 Lunch and Learn April 22, 2015 Office of Human Research.
ASEF Risk Communication for Public Health Emergencies, 2015 Overview.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Is IRB Review or an OHSRP Determination Required?.
Facilitate Group Learning
Human Subjects Protection Program Office of Research Compliance Navigating through the current HSPP and IRB Presented by: Danielle Griffin, M.S. Research.
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
Unit 9: Evaluating a Public Health Surveillance System #1-9-1.
Clarifying Roles and Responsibilities Patients and Other Stakeholders as Study Team Advisors and Members This project is funded by a Patient-Centered Outcomes.
Does My Project Require HRPP/IRB Review? Research Human Subject Engagement HUMAN RESEARCH PROTECTION PROGRAM (HRPP) OFFICE.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Increased # of AI/AN receiving in- home environmental assessment and trigger reduction education and asthma self-management education Increased # of tribal.
Karen Cheung, MPH, Pamela Luna, DrPH, MST, Sarah Merkle, MPH American Evaluation Association Annual Meeting November 11, 2009 The findings and conclusions.
Improved socio-economic services for a more social microfinance.
DATA COLLECTION METHODS IN NURSING RESEARCH
Dean of the School of Nursing at Widener University
Presentation Developed for the Academy of Managed Care Pharmacy
Module 3: Orientation to Research
University of Central Florida Office of Research & Commercialization
Module 4: Developing a Research Agenda
MUHC Innovation Model.
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
shades of gray: When is IRB approval required?
Research Ethics Matthew Billington
University of Central Florida Office of Research & Commercialization
Presentation Developed for the Academy of Managed Care Pharmacy
Does My Project Require HRPP/IRB Review?
Community Scientist Academy
Webinar #3P: How you can contribute to research
Does My Project Require HRPP/IRB Review?
Presentation Developed for the Academy of Managed Care Pharmacy
Research Compliance: Protections for Research Subjects
Stirling Bryan, PhD Scientific Director, BC SUPPORT Unit
Presentation transcript:

Introduction to Human Subjects Protection Challenges in Patient- Centered Outcomes Research (PCOR) Toward Establishing a Stakeholder Community and Action Plan This project is funded by a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington Engagement Award Program (EAIN-2299, PI: Bevans)

Thank you for joining! This is the first of a 3-part webinar series on the protection of human subjects in patient-centered outcomes research (PCOR) Overview of site functionality -Polling feature -Comments/Questions -This session will be recorded

Stakeholders at the Table PCOR ResearchersIRB Members & Leaders Patients & Families Katherine Bevans Assistant Professor of Pediatrics, CHOP Amy Schwartzoff Director, Human Subjects Research CHOP Megan Kasimatis Singleton Associate Director University of Pennsylvania Amy Kratchman Family Consultant Darlene Barkman Family Consultant Anna de la Motte Project Manager, CHOP Researchers: 55 (55%) IRB Affiliates: 39 (39%) Patients & Families: 6 (6%) Megan Morash IRB Chair, Partners Healthcare Researchers have been asking questions like… Do I need IRB approval to engage patients and other stakeholders in my research? IRB members have been asking questions like… Under what circumstances are patients and other stakeholders "human subjects?" Patients and other stakeholder contributors have been asking questions like… Is my personal information kept safe if I’m not signing a formal consent form? Alison Rein AcademyHealth

What makes PCOR unique? Patient and other stakeholder engagement “meaningful involvement of patients, caregivers, clinicians, and other healthcare stakeholders throughout the research process— from topic selection through design and conduct of research to dissemination of results. In unique ways, not typical of traditional research” – PCORI Traditional Research Patient-Engaged Research Patients and Families (Research Participants) Researchers Clinicians Community Leaders Researchers Patients and Families Policy Makers Educators

Challenges to Patient and Other Stakeholder Protection Patient and other stakeholder roles in PCOR are not limited to that of human subjects/research participants Significant challenges are:  Protection of patient and other stakeholder contributors to research (not acting as human subjects)  Preparing patient/other stakeholder contributors to uphold the principles of ethical research

Overview of Human Subjects Protection Research  Systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.  An activity that involves a prospective research plan which incorporates data collection, either quantitative or qualitative, and data analysis to answer a research question.

Human Subject - a living individual about whom a researcher obtains: (1) Data through intervention or interaction with the individual, or (2) Identifiable private information. Overview of Human Subjects Protection

Evolution of This Work PCORI Pilot Project Leaning Network (PPPLN) - AcademyHealth  65% of Pilot Project teams experienced one or more human subjects protection or IRB-related challenged (considered unique to PCOR)  Investigator questionnaire (n=31) and IRB leader interviews (n=5) revealed 3 common challenges: 1.Is the activity research? 2.Is the patient/other stakeholder a “human subject?” 3.How can research teams prepare patient/other stakeholder partners to uphold the principles of human subject protection? Need for guidance/strategies on these and other issues:  Community of stakeholders with diverse perspectives  Identifying and prioritize concerns

Purpose of the Webinar Series 1.Develop and evaluate a process for sharing actionable strategies for addressing human subjects protection challenges in PCOR; 2.Establish a community of stakeholders who seek to advance the ethical conduct of PCOR; 3.Identify high priority challenges to the ethical conduct of PCOR.

Consider the Following Scenario: A team aims to evaluate the impact of diabetes self-management education programs on self-care behaviors, symptoms, functioning, and quality of life. The team met with a group of 5 people with diabetes on three occasions. These people are called “patient contributors.” During the meetings, the patient contributors responded to the team’s questions about…  Critical features of diabetes self-management education programs e.g., What should the programs cover?  Important outcomes of diabetes self-management education programs e.g., How do patients want the programs to improve their lives?  Ways of assessing patient outcomes e.g., Do the surveys do a good job of measuring outcomes that matter to patients?  Recruitment strategies e.g., What are the best ways to recruit patients into the study?  Helping researchers understand study results e.g., Why do some patients (but not others) have fewer symptoms after completing the program?

Polling Question #1 Do researchers need to obtain informed consent from the patient contributors for their involvement in this study?  YES  NO  MAYBE

Polling Question #1 Results yes27% no41% maybe32% Do researchers need to obtain informed consent from the patient contributors for their involvement in this study?

Stakeholder Perspectives: IRB Leaders The patient contributors are NOT human subjects. This is preliminary discussion with patient contributors to plan research project. It describes a prospective plan to evaluate the impact of diabetes education programs and their outcomes. Is this research ? No Patient contributor role ? Yes Study staff Study advisorHuman subject Involved in scientific design; collection of identifiable data; analysis of individual data; participation in research intervention Contribute to study planning or research question formulation; advise in recruitment strategies; participate in survey development Participation in focus group and sharing identifiable information Consent is not required. Consent required.

Stakeholder Perspectives: Researchers Patient partners’ expertise commonly stems from their personal experiences.  In sharing this expertise, patient advisors and study team members often disclose personal health information (even if they are not explicitly asked to do so).  Obtaining feedback from patient advisors often “feels” a lot like a focus group. E.g., obtaining patient feedback on survey content How can researchers protect patient advisor/team members’ privacy? What about dual roles?

Stakeholder Perspectives: Patient & Family Partners “I just assume I’m protected. We heard this a lot from other patient and family partners in research. The hope is that you and your information is being protected.” “Am I protected if I’m on the ‘other’ side (i.e. as an advisor)? I’m still giving information that’s personal information, and it’s being used to guide things. So is that protected information?”

A team aims to evaluate the impact of diabetes self-management education programs on self-care behaviors, symptoms, functioning, and quality of life. The researchers invited 5 people with diabetes to contribute to the study by:  Enrolling patient participants (human subjects) in the study e.g., providing potential participants with information about the study, engaging in the informed consent process  Collecting data e.g., Administering questionnaires to patient participants Consider the Following Scenario:

Polling Question #2 The patient contributors’ role in this scenario is best classified as:  HUMAN SUBJECT/RESEARCH PARTICIPANT  ADVISOR TO THE RESEARCH TEAM  MEMBER OF THE RESEARCH TEAM  I DON’T KNOW

Polling Question #2 Responses Don't Know4% Study Team Member67% Advisor22% Human Subject7% The patient contributors’ role in this scenario is best classified as:

Polling Question #3 Should the 5 patient contributors be required to complete training in the protection of human subjects?  YES  NO  MAYBE

Polling Question #3 Responses yes86% no9% maybe5% Should the 5 patient contributors be required to complete training in the protection of human subjects?

Polling Question #4 Are existing human subjects protection training programs appropriate for patient contributors?  YES  NO  I DON’T KNOW Please list recommended training programs in the comments box.

Polling Question #4 Response Yes31% No56% Don’t know13% Are existing human subjects protection training programs appropriate for patient contributors?

Stakeholder Perspectives: IRB Leaders & Researchers  In order to best protect the “subjects” of research some training in human subjects protections is felt to be important for all individuals who may interact with subjects or their identifiable data  Most of the training programs currently available are primarily designed to address the responsibilities of the researcher and are not appropriately tailored to the potential roles of community partners  Targeted training is needed that better addresses human subjects protections within the context of the roles community partners might have

Stakeholder Perspectives: Patient & Family Partners If I’m recruiting people, or collecting their information, shouldn’t I know about how to protect those subjects?  How can I learn how to protect research participants? If I don’t have training as a researcher or a research assistant, how am I expected to learn all of it? Who is responsible for making sure that I’m trained? Who do I go to if I have questions about the protection of human subjects?  Or, if there are parts of the training that you don’t understand who do you go to?

Summary of Notable Challenges Determining whether an activity that involves a patient or other stakeholder is “research.” Categorizing patients/other stakeholders according to their role(s) in research (e.g., human subject, advisor, study team member).  For each role, specifying…  Patient/other stakeholder responsibilities and limits  Principal Investigator responsibilities  Training needs

Upcoming Webinars Monday, February 8 th (3:00pm-5:00pm EST) Clarifying Definitions: Who is a human subject? Is it research? Monday, February 29 th (3:00pm-5:00pm EST) Preparing Patients and Other Stakeholders to Uphold Ethical Research Principles If you know of anyone who may be interested in attending a future webinar, please send them the handout provided. In particular, please help us to grow our community of patients and other stakeholders!

Next Steps: We need your input!  Help us revise topics and identify speakers for remaining webinars  Webinar satisfaction survey  Help us generate a stakeholder-informed, prioritized list of challenges  Brief (<10 minute) open-ended questionnaire or telephone- based interview to identify additional challenges  Online activity to generate, refine, and prioritize challenges Guidance may be developed for the most highly prioritized challenges.

Thank you! Contact us at: Katherine Bevans (Project Leader) Anna de la Motte (Project Manager)